HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

The company closed on its acquisition of WageWorks and is now the largest HSA administrator in the country.

HealthEquity's Growth Slows as Management Focuses on the Long Term

HealthEquity (HQY) gains from solid segmental contributions in second-quarter fiscal 2020.

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q2

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q2 2020 Results - Earnings Call Transcript

Highlights of the second quarter include:

HealthEquity Reports Second Quarter Ended July 31, 2019 Financial Results

HealthEquity is posting Q2 results after the close, the firm's first report since acquiring WageWorks in a deal that combined two of the largest U.S. HSA operators.

HealthEquity To Post Earnings For First Time Since This Big Acquisition

WageWorks

HealthEquity (HQY) expects to complete its $80-100 million investment program within 24-36 months from now.

HealthEquity Acquires WageWorks, To Make Notable Investments

Higher revenues and possible margin expansion are likely to aid HealthEquity (HQY) in Q2 earnings.

What's in the Cards for HealthEquity (HQY) in Q2 Earnings?

Announces $80-100 Million Investment in Remarkable Service Announces $80-100 Million Investment in Remarkable Service

HealthEquity Completes Acquisition of WageWorks

SAN MATEO, Calif., Aug.  28, 2019  (GLOBE NEWSWIRE) -- WageWorks, Inc. (“WageWorks”) (NYSE: WAGE), a leader in Health Savings Accounts and other Consumer-Directed Benefits, today announced that its stockholders voted to adopt the agreement pursuant to which WageWorks would be acquired as a wholly-owned subsidiary of HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity") in an all-cash transaction. 

WageWorks Stockholders Approve Acquisition by HealthEquity

WageWorks Inc. WAGE, +0.02% said Tuesday it has received an unsolicited letter of interest from Mansa Parent Corp.

WageWorks board rejects unsolicited letter of interest from Mansa, urges shareholders to vote for HealthEquity bid

HealthEquity (HQY) closed at $58.62 in the latest trading session, marking a +0.15% move from the prior day.

HealthEquity (HQY) Gains But Lags Market: What You Should Know

HealthEquity has announced the acquisition of WageWorks at a ~2 Billion valuation.

Taking A Look Into What HealthEquity Has Purchased

In the latest trading session, HealthEquity (HQY) closed at $60.69, marking a -0.51% move from the previous day.

HealthEquity (HQY) Stock Moves -0.51%: What You Should Know

Enphase Energy

iRobot

Inject a little (or a lot) of growth into your portfolio with these three companies.

3 High-Growth Stocks: That Are Just Getting Started.

Shares of the health savings account provider have been just what the portfolio doctor ordered in 2019.

Why HealthEquity Stock Soared 25% in July

HealthEquity (HQY) closed at $77.80 in the latest trading session, marking a -0.13% move from the prior day.

HealthEquity (HQY) Stock Sinks As Market Gains: What You Should Know

AMN Healthcare Services

AMN vs. HQY: Which Stock Is the Better Value Option?

AMN or HQY: Which Is the Better Value Stock Right Now?

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think " Yes "

In the latest trading session, HealthEquity (HQY) closed at $81.91, marking a +0.92% move from the previous day.

HealthEquity (HQY) Gains As Market Dips: What You Should Know

EVP, Counsel & Secretary of Healthequity Inc (30-Year Financial, Insider Trades) Delano Ladd (insider trades) sold 6,875 shares of HQY on 07/22/2019 at an average price of $80 a share.

Healthequity Inc (HQY) EVP, Counsel & Secretary Delano Ladd Sold $550,000 of Shares

HealthEquity boasts of solid performance across all key aspects of business.

HealthEquity: A Unique Pick In The Health Services Segment

BlackLine

Chegg

Five Below

Canada Goose Holdings

nLIGHT Inc

Shopify

Veeva Systems

Wisdomtree Investments

Wingstop

It’s not often you find a small-cap stock fund with almost $4 billion in assets. Here are 10 stocks to buy from Alger Small Cap Focus Fund.

10 Stocks to Buy From This Superstar Fund

Medpace Holdings

Near-Term Outlook for Medical Services Industry Looks Bright

DXC Technology

G-III Apparel Group

OPKO Health

W&T Offshore

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Weekly CEO Buys Highlight (July 21)

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it.

News for HealthEquity Stock (HQY)